3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
11
Completed
11
Active not recruiting
5
Unknown
3
Terminated
3
Not yet recruiting
3
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
369
Neoplasms
253
Carcinoma, Non-Small-Cell Lung
224
Prostatic Neoplasms
192
Lung Neoplasms
140
Colorectal Neoplasms
137
Neoplasm Metastasis
132
Pancreatic Neoplasms
131
Leukemia, Myeloid, Acute
126
Multiple Myeloma
122
Lymphoma
114
Carcinoma, Hepatocellular
111
Ovarian Neoplasms
98
Melanoma
97
Recurrence
93
Leukemia
88
Head and Neck Neoplasms
88
Leukemia, Lymphocytic, Chronic, B-Cell
86
Brain Neoplasms
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Glioblastoma
77
Lymphoma, Non-Hodgkin
73
Squamous Cell Carcinoma of Head and Neck
71
Lymphoma, Follicular
70
Lymphoma, Large B-Cell, Diffuse
66
Colonic Neoplasms
66
Carcinoma, Renal Cell
61
Hematologic Neoplasms
59
Sarcoma
55
Glioma
53
Interventions
atezolizumab
1
PROSTVAC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Interventional
×
Prostate Adenocarcinoma
×
Clear all
NCT04020094
2021-09-22
AtezoVax
University of Utah
Phase 2
Withdrawn